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Abstract: Purpose: To evaluate and compare corneal hysteresis (CH), corneal resistance factor
(CRF), and central corneal thickness (CCT), measurements were taken between a healthy population
(controls), patients diagnosed with glaucoma (DG), and glaucoma suspect patients due to ocular
hypertension (OHT), family history of glaucoma (FHG), or glaucoma-like optic discs (GLD). Addi-
tionally, Goldmann-correlated intraocular pressure (IOPg) and corneal-compensated IOP (IOPcc)
were compared between the different groups of patients. Methods: In this prospective analytical-
observational study, a total of 1065 patients (one eye of each) were recruited to undergo Ocular
Response Analyzer (ORA) testing, ultrasound pachymetry, and clinical examination. Corneal biome-
chanical parameters (CH, CRF), CCT, IOPg, and IOPcc were measured in the control group (n = 574)
and the other groups: DG (n = 147), FHG (n = 78), GLD (n = 90), and OHT (n = 176). We performed
a variance analysis (ANOVA) for all the dependent variables according to the different diagnostic
categories with multiple comparisons to identify the differences between the diagnostic categories,
deeming p < 0.05 as statistically significant. Results: The mean CH in the DG group (9.69 mmHg)
was significantly lower compared to controls (10.75 mmHg; mean difference 1.05, p < 0.001), FHG
(10.70 mmHg; mean difference 1.00, p < 0.05), GLD (10.63 mmHg; mean difference 0.93, p < 0.05) and
OHT (10.54 mmHg; mean difference 0.84, p < 0.05). No glaucoma suspects (FHG, GLD, OHT groups)
presented significant differences between themselves and the control group (p = 1.00). No statistically
significant differences were found in the mean CRF between DG (11.18 mmHg) and the control group
(10.75 mmHg; mean difference 0.42, p = 0.40). The FHG and OHT groups showed significantly higher
mean CRF values (12.32 and 12.41 mmHg, respectively) than the DG group (11.18 mmHg), with
mean differences of 1.13 (p < 0.05) and 1.22 (p < 0.001), respectively. No statistically significant differ-
ences were found in CCT in the analysis between DG (562 µ) and the other groups (control = 556 µ,
FHG = 576 µ, GLD = 569 µ, OHT = 570 µ). The means of IOPg and IOPcc values were higher in the
DG patient and suspect groups than in the control group, with statistically significant differences in
all groups (p < 0.001). Conclusion: This study presents corneal biomechanical values (CH, CRF), CCT,
IOPg, and IOPcc for diagnosed glaucoma patients, three suspected glaucoma groups, and a healthy
population, using the ORA. Mean CH values were markedly lower in the DG group (diagnosed
with glaucoma damage) compared to the other groups. No significant difference was found in CCT
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between the DG and control groups. Unexpectedly, CRF showed higher values in all groups than in
the control group, but the difference was only statistically significant in the suspect groups (FHG,
GLD, and OHT), not in the DG group.
Keywords: glaucoma; corneal hysteresis; ocular inflammation; corneal biomechanics; ocular biomarkers
1. Introduction
Corneal biomechanics studies the balance and deformation of the corneal tissue
subjected to any external action. This scientific discipline explores the function and the
inner structure of the cornea and endeavors to establish some physical-mathematical
bases that define it [1]. The possible practical applications range from the diagnosis and
assessment of certain pathologies [2–5] to the prediction of response to corneal surgical
procedures [6–9].
The Ocular Response Analyzer, ORA (Reichert), was the first device to measure
the biomechanical properties of the cornea in vivo. It can determine some parameters
of the structure and viscoelastic properties of the cornea, and also intraocular pressure
(IOP) [10]. Corneal biomechanical parameters measured by ORA are corneal hysteresis
(CH) and corneal resistance factor (CRF), as well as noncontact intraocular pressures,
such as the Goldmann-correlated intraocular pressure (IOPg) and corneal-compensated
intraocular pressure (IOPcc). Several studies have tried to set biomechanical parameters
to help improve prediction of corneal ectasia, refractive surgery pre- and post-operative
evaluation, corneal pathologies, and glaucoma. It has been shown that CH is lower
after refractive surgery in corneal ectasia, such as in keratoconus, Fuchs’ dystrophy, and
glaucoma patients [11–15]. Glaucoma is a chronic and progressive optic neuropathy
characterized by loss of the retinal nerve fiber layer, progressive optic disc damage, and the
development of characteristically evolving visual field defects. It is associated, although not
in all cases, with an increase in IOP. The prevalence of glaucoma is 1.5%–2% in individuals
over 40 years of age and even higher in those over 60 years of age. Glaucoma is an especially
relevant ocular pathology, since it is the second cause of irreversible blindness after diabetic
retinopathy. The most common type, accounting for 60% of glaucoma cases, is primary
open-angle glaucoma (POAG). It is usually bilateral, although frequently asymmetric,
and the chamber angle is open and is not related to another ocular disorder. The exact
etiology of POAG is unknown, but there are some risk factors, including IOP, family
history, increasing age, race, myopia, and cardiovascular status [15,16]. It is currently
known that, although an increase in IOP is the most important risk factor for suffering
from glaucoma and the only one on which we can act at the moment, it is not the only
determining factor. Some facts support these claims, suggesting that other risk factors
should be considered: There are patients who present an IOP of over 21 mmHg (even
30 mmHg) but do not present alterations in the optic nerve or in the visual field. They are
called ocular hypertensive or glaucoma suspects, and although some develop glaucoma
(40% in 10 years), others remain unaffected despite elevated intraocular pressure values.
Another group of patients present visual field examination and optic nerve head alterations
typical of glaucoma, with normal IOP values or even lower than usual, a circumstance that
we call low-tension glaucoma or normal-tension glaucoma [17]. It has been reported that
45% of treated glaucoma patients had glaucomatous progression in visual fields despite
an average 25% decrease in IOP [18]. Even so, IOP is the only factor on which we can act
to stop the progress of the disease and to which all anti-glaucoma treatments have been
directed so far.
In the last decade, the biomechanical properties of the cornea have received increasing
attention, particularly corneal hysteresis (CH). Corneal biomechanics provides insight into
the behavior of the cornea and could reflect the vulnerability of the optic nerve structures
to glaucoma. Thus, CH could become a potential glaucoma biomarker, which could serve
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as a risk indicator of progression. Besides CH, a new compensated IOP (IOPcc) would
show a more real IOP value. The analysis, study, and assessment of corneal biomechanical
properties, IOPcc, and corneal thickness obtained with the ORA in normal eyes, in eyes
with glaucoma, and in eyes with suspected glaucoma, provide new data that can help
identify patients with a higher risk of glaucoma progression.
The purpose of this study was to evaluate and compare CH and central corneal
thickness (CCT) measurements between a healthy population (controls), patients diagnosed
with glaucoma (DG) in treatment for IOP control, and glaucoma suspect patients due to
ocular hypertension (OHT) or other risk factors, such as family history of glaucoma (FHG)
or glaucoma-like optic discs (GLD) [19]. Additionally, the corneal resistance factor (CRF),
Goldmann-correlated intraocular pressure (IOPg), corneal-compensated IOP (IOPcc), and
CCT are evaluated and compared between the different groups of patients. Furthermore,
the study of a large control group defines the mean values of corneal biomechanical
properties and IOP in the healthy Spanish population.
2. Methods
This is a prospective analytical-observational study that was performed at the Anterior
Segment section of the Department of Ophthalmology, Hospital Clínico Universitario
Lozano Blesa, Saragossa (Spain). The study was approved by the Institutional Review
Board of the University of Saragossa Faculty of Medicine and was conducted in accordance
with the Declaration of Helsinki for research involving human subjects. The studywas
approved by the Ethics Committee for Clinical Research of Aragon (CEICA 18/2017)
and the date of approval was 25 October 2017. Written informed consent was signed by
all participants.
2.1. Subjects
Subjects included in this study were healthy persons without a diagnosed ocular
pathology (controls), patients diagnosed with glaucoma (DG), and glaucoma suspect
patients who were undergoing a study for early diagnosis due to ocular hypertension
(OHT), family history of glaucoma (FHG), or glaucoma-like optic discs (GLD).
Subjects excluded from this study were patients with serious general diseases, such as
recent surgery, malignant neoplastic pathology, collagen diseases, immunological diseases,
metabolic stress due to moderate-severe renal failure, decompensated diabetes mellitus,
altered nutritional status, or any general situation of the patient that could compromise
the results of the evidence. Further exclusion criteria were patients with other ocular
pathologies, such as severe dry eye syndrome, corneal chemical burn, infectious and
inflammatory diseases of the cornea, conjunctiva, uvea and sclera; corneal ectasia or
dystrophies; acute pathologies and postsurgical states, such as retinal detachment, acute
glaucoma, proliferative diabetic retinopathy, iris rubeosis, need for valve implants due to
glaucoma, patients undergoing any corneal surgery, or patients who presented signs of
corneal pathology.
2.2. Examination Techniques
All participants underwent exhaustive ophthalmologic examination, including a
review of medical history, slit-lamp biomicroscopy, best-corrected visual acuity, IOP mea-
surement using Goldmann applanation tonometry (GAT), and retinal ophthalmoscopy
examination. The clinical examinations necessary for the diagnosis and evolutionary as-
sessment of the patients were carried out following an action protocol specific to the ocular
pathology group to which they belonged. The entire battery of diagnostic devices typical
of a hospital ophthalmology department were available to us to perform this study. These
included a refractometer, indirect ophthalmoscope, optical coherence tomography (OCT),
ORBSCAN ocular topography, endothelial analysis with a non-contact specular microscope,
and standard automated perimetry (SAP).
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In the group of healthy patients, topographic exploration with ORBSCAN was also
performed on those patients with refractive defects (to rule out evident keratoconus or sub-
clinical keratoconus), as was specular microscopy on patients with doubtful biomicroscopy
or high corneal thickness suspected of edema. If any corneal pathology was evidenced, the
patient was excluded from the study.
In the DG group, functional diagnostic tests with standard automated perimetry (SAP),
the Swedish Interactive Threshold Algorithm (SITA), 24–2 testing of the HVS Analyzer II,
model 750i (Carl Zeiss Meditec, Inc., Dublin, CA, USA), and structural tests (fiber and
papilla OCT) were performed to assess glaucomatous damage.
Examination was completed with gonioscopy, stereoscopic optic disc photography,
functional tests with SAP, and structural tests (OCT of fibers and papilla) in the glaucoma
suspect groups (OHT, FHG, or GLD). If there was evidence of unknown glaucomatous
damage, treatment was prescribed, and the patient was excluded from the study. Ocular
hypertension was defined as IOP equal to or higher than 21 mmHg with a normal visual
field and optic nerve. Family history of glaucoma was determined as at least one of the
parents with diagnosed glaucoma. Glaucoma-like optic discs were defined as having a
vertical cup-to-disc ratio greater than 0.5 or asymmetry of cupping between the two eyes
in patients with normal IOP and visual fields and open angles.
All patients were explored with Reichert’s Ocular Response Analyzer (ORA), both
to determine their biomechanical properties (CH, CRF) and to determine their Goldman
equivalent IOP (IOPg) and compensated IOP (IOPcc). The central corneal thickness (CCT)
was determined from the pachymetry performed with the ultrasonic pachymeter incorpo-
rated in the ORA. All ocular examinations, including ORA, were performed on the same
day. Four consecutive ORA measurements were determined in both eyes. Then the results
were averaged. One eye of each patient was chosen at random.
2.3. Statistical Analysis
A total of 1065 patients (one eye of each) were recruited in this prospective analytical-
observational study. Normal subjects comprised the control group (n = 574), who were
studied alongside the DG (n = 147), FHG (n =78), GLD (n = 90), and OHT (n = 176)
diagnosis groups. Microsoft Excel was used to collate data including patient age and
gender, diagnosis group, CH, CRF, IOPg, IOPcc, and CCT. The IBM SPSS (version 17)
statistical package was used for data analysis. An analysis of variance (ANOVA) was
carried out for all the dependent variables according to the different diagnostic categories,
with multiple comparisons to distinguish between the diagnostic categories in which there
were differences, taking p < 0.05 as statistically significant.
3. Results
3.1. Subjects
The study included one eye of each of the 1065 patients. Table 1 summarizes the basic
demographic information for the patients included in the five different diagnosis groups.
A higher percentage of females was present in the FHG (71.8%) and GLD groups (78.9%)
compared to the control (50.7%), OHT (54%), and DG (44.2%) groups. The control group
patients were younger, on average, than the patients included in the other four groups.
After carrying out a comparative study of the control group with the pathological groups,
we found the following results for each variable using the ORA (CH, CRF, IOPg, IOPcc,
and CCT), which are summarized in Table 2 and Figures 1 and 2.
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Table 1. Demographics of the control and the four diagnosis groups included in the study (DG, FHG,













Female 291 (50.7%) 65 (44.2%) 56 (71.8%) 71 (78.9%) 95 (54%) 578 (54.3%)
Male 283 (49.3%) 82 (55.8%) 22 (28.2%) 19 (21.1%) 81 (46%) 487 (45.7%)
Age
(years) 39 ± 15 56 ± 16 47 ± 15 48 ± 14 51 ± 13 46 ± 17
DG—diagnosed glaucoma; FHG—family history of glaucoma; GLD—glaucoma-like optic discs; OHT—ocular
hypertension; SD—standard deviation.
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DG—diagnosed glaucoma; FHG—family history of glaucoma; GLD—glaucoma-like optic discs; OHT—ocular
hypertension; SD—standard deviation. IOPg: Goldmann-correlated intraocular pressure, IOPcc: corneal-
compensated IOP, CH: Corneal Hysteresis, CRF: Corneal Resistance Factor, CCT: Central Corneal Thickness.




Figure 1. Plot of meanCorneal Hysteresis (CH), Corneal Resistance Factor (CRF), Gold-
mann-correlated intraocular pressure (IOPg) and corneal-compensated IOP (IOPcc) val-
ues in all groups. DG—diagnosed glaucoma; FHG—family history of glaucoma; GLD—
glaucoma-like optic discs; OHT—ocular hypertension.
 
Figure 2. Plot of mean Central Corneal Thickness (CCT) values in all groups. DG—diagnosed glaucoma; 
FHG—family history of glaucoma; GLD—glaucoma-like optic discs; OHT—ocular hypertension. 
Table 1. Demographics of the control and the four diagnosis groups included in the study (DG, 
FHG, GLD, and OHT). Gender is summarized by frequency and percentage; age by mean ± SD. 
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(n = 574) 
DG 
(n = 147) 
FHG 
(n = 78) 
GLD 
(n = 90) 
OHT 
(n = 176) 
Total 
(n =1 065) 
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Male 283 (49.3%) 82 (55.8%) 22 (28.2%) 19 (21.1%) 81 (46%) 487 (45.7%) 
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DG—diagnosed glaucoma; FHG—family history of glaucoma; GLD—glaucoma-like optic discs; 
OHT—ocular hypertension; SD—standard deviation. 
Figure 1. Plot of meanCorneal Hysteresis (CH), Corneal Resistance Factor (CRF), Goldmann-
correlated intraocular pressure (IOPg) and corneal-compensated IOP (IOPcc) values in all groups.
DG—diagnosed glaucoma; FHG—family history of glaucoma; GLD—glaucoma-like optic discs;
OHT—ocular hypertension.
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3.1.1. CH
The mean CH in DG patients (9.69 ± 1.9 mmHg) was lower than in the control
group (10.75 ± 1.5 mmHg). Additionally, the mean CH in DG patients was lower than
in all glaucoma suspect groups: FHG, GLD, and OHT (10.70 ± 1.7, 10.63 ± 1.9, and
10.54 ± 1.8 mmHg, respectively). The scatter graphs for the CH variable according to the
groups studied show a minimal dispersion in the control group and a greater dispersion in
the DG group and in the glaucoma suspect groups (FHG, GLG, and OHT). Figure 3 shows
the comparison of the mean values (left) and the scatter graphs (right) of the CH variable
in all groups. An i ferential tatistical study was carried out to verify the significance of
these differences, using the ANOVA multiple comparisons test (Table 3), which shows the
existence of statistically significant differences (p < 0.05) for the CH variable comparing
the DG group with the rest of the groups. No significant differences were found between
the control group and the glaucoma suspect groups (p = 1.00). The FHG, GLD, and OHT
groups showed no significant differences between themselves (p = 1.00).
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Table 3. Statistical results using ANOVA multiple comparisons test for the CH variable.
Dependent





Upper Limit Lower Limit
CH Control DG 1.053 (*) 0.174 0.000 * 0.502 1.604
FHG 0.052 0.207 1.000 −0.611 0.717
GLD 0.119 0.216 1.000 −0.572 0.811
OHT 0.210 0.153 0.995 −0.272 0.693
DG Control −1.053 (*) 0.174 0.000 * −1.604 −0.502
FHG −1.000 (*) 0.254 0.003 * −1.807 −0.194
GLD −0.934 (*) 0.262 0.013 * −1.763 −0.104
OHT −0.842 (*) 0.213 0.003 * −1.513 −0.172
FHG Control −0.052 0.207 1.000 −0.717 0.611
DG 1.000 (*) 0.254 0.003 * 0.194 1.807
GLD 0.066 0.285 1.000 −0.836 0.970
OHT 0.157 0.240 1.000 −0.605 0.921
GLD Control −0.119 0.216 1.000 −0.811 0.572
DG 0.934 (*) 0.262 0.013 * 0.104 1.763
FHG −0.066 0.285 1.000 −0.970 0.836
OHT 0.091 0.248 1.000 −0.696 0.879
OHT Control −0.210 0.153 0.995 −0.693 0.272
DG 0.842 (*) 0.213 0.003 * 0.172 1.513
FHG −0.157 0.240 1.000 −0.921 0.605
GLD −0.091 0.248 1.000 −0.879 0.696
SE—standard error, * Statistical significance (p < 0.05), CI—confidence interval, DG—diagnosed glaucoma; FHG—family history of
glaucoma; GLD—glaucoma-like optic discs; OHT—ocular hypertension.
3.1.2. CRF
The glaucoma suspect groups (FHG, GLD, and OHT) showed higher CRF values
(12.32 ± 1.9, 11.50 ± 1.9, and 12.41 ± 1.8 mmHg, respectively) than the control group
(10.75 ± 1.6 mmHg) with statistically significant differences (p < 0.001, p < 0.05, and
p < 0.001, respectively). No statistically significant differences were found between the
DG group and the control group. In the comparative study of the DG group versus the
glaucoma suspect groups (FHG, GLD, and OHT), the FHG and OHT groups presented
higher CRF values and the differences were significant (p < 0.05 and p < 0.001, respectively)
(Table 4).
3.1.3. IOPg
The DG group and the glaucoma suspect groups (FHG, GLD, and OHT) presented
higher IOPg values (20.07 ± 3.6, 21.01 ± 4.0, 18.48 ± 3.6, and 21.76 ± 3.6 mmHg, respec-
tively) than the control group (15.63 ± 3.1 mmHg) with statistically significant differences
(p < 0.001). The DG group had significantly lower IOPg than the OHT group (p < 0.05)
and significantly higher IOPg than the GLD group (p < 0.05). The GLD group presented
significantly lower IOPg values than the DG (p < 0.05), FHG (p < 0.001), and OHT (p < 0.001)
groups (Table 5).
3.1.4. IOPcc
The DG group and the glaucoma suspect groups (FHG, GLD, and OHT) presented
higher IOPcc values (20.68 ± 3.7, 20.41 ± 3.8, 18.30 ± 3.9, and 21.22 ± 3.8 mmHg, re-
spectively) than the control group (15.72 ± 3.0) with statistically significant differences
(p < 0.001). When comparing the DG group with the glaucoma suspect groups, the IOPcc
values were found to be significantly lower in the GLD group (p < 0.001). The OHT group
presented no differences when compared with the DG group, since the IOPcc values were
lower than those of IOPg in this group (Table 6).
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Table 4. Statistical results using ANOVA multiple comparisons test for the CRF variable.
Dependent
Variable




Upper Limit Lower Limit
CRF Control DG −0.429 0.180 0.403 −0.998 0.140
FHG −1.562 (*) 0.235 0.000 * −2.317 −0.808
GLD −0.745 (*) 0.214 0.020 * −1.430 −0.060
OHT −1.653 (*) 0.155 0.000 * −2.144 −1.163
DG Control 0.429 0.180 0.403 −0.140 0.998
FHG −1.133 (*) 0.279 0.002 * −2.018 −0.249
GLD −0.316 0.262 0.999 −1.145 0.511
OHT −1.224 (*) 0.216 0.000 * −1.906 −0.543
FHG Control 1.562 (*) 0.235 0.000 * 0.808 2.317
DG 1.133 (*) 0.279 0.002 * 0.249 2.018
GLD 0.816 0.302 0.193 −0.141 1.775
OHT −0.091 0.263 1.000 −0.929 0.747
GLD Control 0.745 (*) 0.214 0.020 * 0.060 1.430
DG 0.316 0.262 0.999 −0.511 1.145
FHG −0.816 0.302 0.193 −1.775 0.141
OHT −0.908 (*) 0.245 0.008 * −1.686 −0.129
OHT Control 1.653 (*) 0.155 0.000 * 1.163 2.144
DG 1.224 (*) 0.216 0.000 * 0.543 1.906
FHG 0.091 0.263 1.000 −0.747 0.929
GLD 0.908 (*) 0.245 0.008 * 0.129 1.686
SE—standard error, * Statistical significance (p < 0.05), CI—confidence interval, DG—diagnosed glaucoma; FHG—family history of
glaucoma; GLD—glaucoma-like optic discs; OHT—ocular hypertension.
Table 5. Statistical results using ANOVA multiple comparisons test for the IOPg variable.
Dependent





Upper Limit Lower Limit
IOPg Control DG −4.435 (*) 0.328 0.000 * −5.472 −3.397
FHG −5.378 (*) 0.474 0.000 * −6.902 −3.854
GLD −2.844 (*) 0.408 0.000 * −4.149 −1.539
OHT −6.130 (*) 0.302 0.000 * −7.083 −5.177
DG Control 4.435 (*) 0.328 0.000 * 3.397 5.472
FHG −0.943 0.546 0.921 −2.680 0.792
GLD 1.590 (*) 0.490 0.039 * 0.038 3.142
OHT −1.695 (*) 0.406 0.001 * −2.974 −0.415
FHG Control 5.378 (*) 0.474 0.000 * 3.854 6.902
DG 0.943 0.546 0.921 −0.792 2.680
GLD 2.534 (*) 0.598 0.001 * 0.636 4.432
OHT −0.751 0.531 0.992 −2.442 0.939
GLD Control 2.844 (*) 0.408 0.000 * 1.539 4.149
DG −1.590 (*) 0.490 0.039 * −3.142 −0.038
FHG −2.534 (*) 0.598 0.001 * −4.432 −0.636
OHT −3.285 (*) 0.474 0.000 * −4.785 −1.785
OHT Control 6.130 (*) 0.302 0.000 * 5.177 7.083
DG 1.695 (*) 0.406 0.001 * 0.415 2.974
FHG 0.751 0.531 0.992 −0.939 2.442
GLD 3.285 (*) 0.474 0.000 * 1.785 4.785
SE—standard error. * Statistical significance (p < 0.05). CI—confidence interval; DG—diagnosed glaucoma; FHG—family history of
glaucoma; GLD—glaucoma-like optic discs; OHT—ocular hypertension.
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Upper Limit Lower Limit
IOPcc Control DG −4.954 (*) 0.335 0.000 * −6.014 −3.895
FHG −4.686 (*) 0.450 0.000 * −6.131 −3.241
GLD −2.577 (*) 0.434 0.000 * −3.966 −1.187
OHT −5.503 (*) 0.314 0.000 * −6.494 −4.513
DG Control 4.954 (*) 0.335 0.000 * 3.895 6.014
FHG 0.268 0.531 1.000 −1.416 1.953
GLD 2.377 (*) 0.518 0.000 * 0.737 4.017
OHT −0.548 0.422 0.998 −1.877 0.779
FHG Control 4.686 (*) 0.450 0.000 * 3.241 6.131
DG −0.268 0.531 1.000 −1.953 1.416
GLD 2.109 (*) 0.599 0.015 * 0.211 4.007
OHT −0.817 0.518 0.969 −2.462 0.828
GLD Control 2.577 (*) 0.434 0.000 * 1.187 3.966
DG −2.377 (*) 0.518 0.000 * −4.017 −0.737
FHG −2.109 (*) 0.599 0.015 * −4.007 −0.211
OHT −2.926 (*) 0.505 0.000 * −4.525 −1.327
OHT Control 5.503 (*) 0.314 0.000 * 4.513 6.494
DG 0.548 0.422 0.998 −0.779 1.877
FHG 0.817 0.518 0.969 −0.828 2.462
GLD 2.926 (*) 0.505 0.000 * 1.327 4.525
SE—standard error. * Statistical significance (p < 0.05). CI—confidence interval. DG—diagnosed glaucoma; FHG—family history of
glaucoma; GLD—glaucoma-like optic discs; OHT—ocular hypertension.
3.1.5. CCT
The DG group and the glaucoma suspect groups (FHG, GLD, and OHT) presented
higher CCT values (562.6 ± 39.6 µ, 576.3 ± 38.3 µ, 569.51 ± 31.5 µ, and 570.34 ± 34.7 µ,
respectively) than the control group (556.8 ± 35.3 µ), but only the FHG and OHT groups
exhibited statistically significant differences (p < 0.05). No significant differences were
found in the comparative analysis of the DG group with respect to the FHG, GLD, and
OHT groups (Table 7).










Upper Limit Lower Limit
CCT Control DG −5.80 4.36 0.997 −19.71 8.10
FHG −19.45 * 5.01 0.006 * −35.64 −3.27
GLD −12.64 4.34 0.122 −26.63 1.35
OHT −13.47 * 3.52 0.005 * −24.62 −2.33
DG Control 5.80 4.36 0.997 −8.10 19.71
FHG −13.64 6.26 0.585 −33.54 6.24
GLD −6.83 5.73 0.999 −25.02 11.35
OHT −7.67 5.14 0.984 −23.92 8.58
FHG Control 19.45 * 5.01 0.006 * 3.27 35.64
DG 13.64 6.26 0.585 −6.24 33.54
GLD 6.81 6.24 1.000 −13.07 26.70
OHT 5.97 5.70 1.000 −12.21 24.16
GLD Control 12.64 4.34 0.122 −1.35 26.63
DG 6.83 5.73 0.999 −11.35 25.02
FHG −6.81 6.24 1.000 −26.70 13.07
OHT −0.83 5.11 1.000 −17.12 15.44
OHT Control 13.47 * 3.52 0.005 * 2.33 24.62
DG 7.67 5.14 0.984 −8.58 23.92
FHG −5.97 5.70 1.000 −24.16 12.21
GLD 0.83 5.11 1.000 −15.44 17.12
SE—standard error. * Statistical significance (p < 0.05). CI—confidence interval. DG—diagnosed glaucoma; FHG—family history of
glaucoma; GLD—glaucoma-like optic discs; OHT—ocular hypertension.
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4. Discussion
4.1. Control Group
This work provides reference values for corneal biomechanical parameters (CH and
CRF), IOPg, IOPcc, and CCT for the healthy Spanish population because it studied such a
large control group (574 eyes). It should be noted that the existence of ocular pathologies
(clinical or subclinical keratoconus, glaucoma, corneal dystrophies, and so on) in the control
group was ruled out, and the study shows the results of a population with a wide age
range. The mean age of the group of healthy control patients was 38.7 years, similar to
that of other published studies [11,14,20,21]. The standard deviation of 15.54 in the age
range (9–84 years) shows an age range of the control group subjects greater than that of
other published works [10,22]. Mean values of CH (10.75 mmHg), CRF (10.75 mmHg),
CCT (556.8 µ), IOPg (15.63 mmHg), and IOPcc (15.72 mmHg) hwere obtained. Means of
the CH values obtained in other studies have ranged from 9.6 to 11.4 mmHg, but it should
be taken into account that disparate population groups were studied regarding race and
age, and moreover, some of them were carried out on a population of subjects with high
refractive errors [23–26]. The mean CH obtained by Shah et al. [13] in healthy subjects was
10.7 ± 2.0, which is similar to that obtained in our work (10.7 ± 1.5). In another European
study carried out on the eyes of healthy subjects [27], mean values of 10.7 ± 1.8 mmHg
were obtained for the CRF, of 10.6 ± 1.6 mmHg for CH, of 15.9 ± 3.9 mmHg for IOPg,
and of 16.2 ± 3.7 mmHg for IOPcc. It can be seen that they are similar to those obtained
in our work, although in their study, they did not rule out the existence of possible
subclinical keratoconus.
The ORA can determine IOPg values correlated to GAT, as well as IOPcc values, and
it is less influenced by corneal biomechanical properties. In our study, we found that the
control group of healthy patients, with normal biomechanical properties, presented similar
mean IOPg and IOPcc values (15.6 mmHg and 15.7 mmHg, respectively). These values
are similar to the GAT means reported in the literature for the healthy population, which
are around 15.5 mmHg. We believe that these results, obtained from a large control group,
validate the ORA as a tonometer, since the value means were determined in a large group of
a healthy population, in which tests, such as topography and pachymetry, were performed
that ruled out corneal subclinical alterations. Ping-Bo et al. [28] conducted a study using
the ORA on 296 eyes of 158 healthy patients, classified into three groups according to
their CCT (<520 µ, 520–580 µ, >580 µ), and found the following mean IOP values (IOPg:
14.95 ± 2.99 mmHg, IOPcc: 15.21 ± 2.77 mmHg, and GAT: 15.22 ± 2.77 mmHg), which are
similar to those obtained in the control group of our work. When analyzing the values
according to the CCT, they concluded that IOPcc measurements with ORA were only
affected to a small extent by CCT, and they are probably much closer to the true value of
the IOP than GAT.
The mean values of the CCT of the healthy population, in most of the published
studies, are between 528µ and 562µ [29–32], which is similar to those obtained in this study
for the healthy control population (556 µ).
4.2. Glaucoma, FHG, and Glaucoma Suspect Groups
In the last 15 years, a large number of articles about corneal biomechanical characteri-
zation have been published [33–38]. In the context of corneal biomechanical parameters of
patients with glaucoma, we previously observed a significant decrease in CH when com-
pared to healthy subjects [39,40]. This coincides with the results of other authors [14,41–43]
who also found a significant decrease in CH in glaucoma, which was particularly evident in
cases of congenital glaucoma [22]. The published results of CRF values are not consistent,
as some have obtained low values [37] and others have obtained high values [35]. Our
study aims to go into greater depth of cases of suspected glaucoma, which are referred to
in this study, either owing to a family history of this pathology or to some doubtful sign,
such as a suspicious papillary excavation or borderline or high IOP values, but without
evident glaucomatous damage that would confirm the diagnosis.
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We carried out a statistical study with multiple comparisons in which we obtained
results for each group; we compared them with those of the control group, and we also
compared them between each other to verify if there were any statistically significant
differences. We found no published study that performs a comparative analysis on these
groups of patients, so the results may have a special impact on the assessment of this
pathology. This study has several limitations, since we did not analyze the evolutionary
data of patients with glaucoma, nor did we differentiate pigmentary from pseudoexfoliative
glaucoma; we did not include a group of normal-tension glaucoma, nor did we assess cases
of angle-closure glaucoma.
4.2.1. CH
In this study, we verified the existence of decreased CH in the DG group compared
to the control group; however, we did not find statistically significant differences in CH
values in the three groups studied for suspected glaucoma and FHG when compared to
the control group. These groups did not present evident glaucomatous lesions in the visual
field or in the OCT fiber study. Consequently, CH could be a promising indicator to predict
the progression of glaucoma, since it determines a specific biomechanical condition that
is found in the cornea, but that could also affect other ocular structures, conditioning a
special susceptibility to suffer glaucomatous damage. Recent studies suggest a possible
relationship between lower CH values and structural changes in the optic nerve associated
with glaucomatous damage. The relationship of low CH values with mean cup depth,
linear cup-to-disc ratio, and greater posterior displacement of the lamina cribrosa has
been evidenced [44–46]. Corneal hysteresis may provide insight into the biomechanical
properties of the optic nerve and its supporting structures.
Some research indicates that eyes with higher IOP have lower CH values, and that
the therapeutic manipulation of IOP can induce an inverse response in CH. It has been
suggested that it may be due to the effect of prostaglandin therapy. Nevertheless, Meda
et al. [47] do not support this hypothesis and suggest that this increase in CH may be due
to IOP control. Furthermore, other medical and surgical treatments have shown to increase
CH. Sun et al. [48] found that CH was significantly lower in eyes with chronic angle-closure
glaucoma (CACG) compared to the contralateral eye and the control group of normal eyes.
On the other hand, in this prospective study, it was found that trabeculectomy decreased
the mean IOP from 31.5 to 11.5 mmHg, and that CH increased from 6.8 to 9.2 mmHg in the
same period, although CH remained lower than in the contralateral eye without CACG.
This study reflects the apparent dependence of CH according to IOP, and the probability
that the regression of high IOP increases the mean of CH in this type of patients.
4.2.2. CRF
In this study, the values of CRF in the DG group showed higher values than the control
group, but we found no statistically significant differences (p > 0.05). FHG, GLD, and OHT
groups showed higher CRF values than the control group, with statistically significant
differences. The OHT group showed the highest CRF values. Pillunat et al. [37] found
that glaucoma patients had the lowest CRF values (9.07 ± 1.93 mmHg) in comparison
to controls (10.2 ± 1.9 mmHg) and OHT patients (CRF: 10.6 ± 2.1 mmHg). However,
Kaushik et al. found that CRF was significantly higher in POAG and OHT, which matches
our results.
4.2.3. CCT
Regarding CCT, in the DG group we found no differences in the CCT of DG patients
compared to those of the control group, which coincides with the results of other au-
thors [14,22,38,42]. Although low CCT influences an underestimation of IOP by GAT [16],
our glaucoma patients did not present different CCT values from those of the normal
population, and the underestimation of IOP by GAT (IOPcc higher than IOPg) in the DG
group could be related to other corneal biomechanical conditions, such as CH.
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4.2.4. CH and CCT
Several studies have analyzed the association between CH and the visual field and
optic nerve deterioration in glaucomatous patients [46,49,50], but the understanding of
the direct importance of CH for glaucoma, and especially its relationship with CCT, is still
evolving. Although it is true that low CCT has been related to the risk of OHT progression to
glaucoma and to the progression of glaucomatous visual field loss, the results of our study
agree with those of other authors, such as Congdon et al. [49], who found an association
of low CH values with greater progression of the glaucomatous visual field, regardless
of the CCT values, in their retrospective observational clinical study. It should be taken
into account that CH is a direct estimate of an aspect of ocular biomechanics measured
in the cornea, while CCT represents only one parameter that affects biomechanics. Wells
et al. [46] found a relationship between low CH and the existence of greater deformation of
the optic nerve after hyperpressure caused by suction in patients with glaucoma, but not
with CCT.
The importance of measurable biomechanical parameters of the cornea has not yet
been fully clarified. We know that CCT influences the estimation of a real IOP. In fact, there
are structurally strong, thick corneas (high CCT, CH, and CRF), as in cases of hyperopic
patients or OHT with high pachymetry values [51–53], where the IOPcc values are lower
than the GAT or IOPg. There are also structurally weak, thick corneas, as in cases of
endothelial dystrophy, bullous keratopathy, or rejection in keratoplasties [12,54]. In Fuchs’
endothelial dystrophy, it has been shown that, when a high CCT value is due to corneal
edema, there is a decrease in the CH and CRF biomechanical parameters. In these cases,
there is no overestimation of IOP due to the increase in CCT, quite the opposite. The GAT
in these patients underestimates the IOP and the IOPcc values show a higher real IOP [12].
The ORA can provide additional interesting information in the study of glaucoma
patients. On the one hand, it provides an IOPcc value that is less influenced by the
biomechanical properties of the cornea, which helps assess each case and, furthermore, it
indicates CH values that can give guidance in the control of patients. The existence of a
low CH value can be considered a risk factor for glaucoma progression. Likewise, in cases
of OHT, the presence of high biomechanical values of CH, CRF, and CCT may indicate a
low risk of progression to glaucoma; these cases usually present lower IOPcc values (in the
normal range) than those of IOPg and GAT.
The present study provides the following conclusions on corneal biomechanics and
IOP with the ORA:
1. A mean CH and CRF value of 10.75 mmHg was established in the healthy control
population, which can be a reference for the Spanish population. The mean IOPg
(15.63 mmHg) and IOPcc (15.72) values estimated by the ORA, in patients without
ocular pathology, were similar to the mean GAT values. IOPg and IOPcc values were
similar when the biomechanical properties of the cornea were within normal limits.
2. The IOPg and IOPcc means were significantly higher than those of the control group in
all glaucoma and glaucoma suspect groups. There was a significant decrease in CH in
the DG group compared to the control group, and with respect to the three glaucoma
suspect groups. However, the CH values in the three glaucoma suspect groups (FHG,
GLD, and OHT) did not show statistically significant differences between them, or
with respect to the control group. No statistically significant differences in CRF
values between the DG group and the control group were found. However, elevated
CRF values in all the glaucoma suspect groups were found, such differences being
statistically significant with respect to the control group. There was no CCT alteration
in the DG group. POAG showed its own biomechanical profile (normal or high CCT,
normal or high CRF, and low CH with IOPcc > IOPg).
3. The OHT and FHG suspect groups presented higher CRF values than the DG group
and the differences were statistically significant. The mean CCT values were higher
than the control group in all groups, although there were no statistically significant
differences. Ocular hypertension suspect cases showed the highest CCT values. OHT
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showed its own biomechanical profile (high CCT, high CRF, and normal or high CH
with IOPcc < IOPg).
Finally, future studies could be performed to compare the biomechanical characteri-
zation of the cornea by two different devices, namely ORA and CORVIS-ST. To date, no
study has found a relationship between the parameters they report. The contribution to
diagnosis of CORVIS-ST has been studied mainly for corneal ectasia, but there is a lack of
data about the differential role of CORVIS parameters in the glaucoma spectrum.
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